Volume 13, Number 5—May 2007
Enteroaggregative Escherichia coli Related to Uropathogenic Clonal Group A
Author affiliations: *Haverford College, Haverford, Pennsylvania, USA;; †Minneapolis Veterans Administration Medical Center, Minneapolis, Minnesota, USA;; ‡University of Minnesota, Minneapolis, Minnesota, USA; and; §Wellcome Trust Sanger Institute, Cambridgeshire, United Kingdom
Highlight and copy the desired format.
|EID||Wallace-Gadsden F, Johnson JR, Wain J, Okeke IN. Enteroaggregative Escherichia coli Related to Uropathogenic Clonal Group A. Emerg Infect Dis. 2007;13(5):757. https://dx.doi.org/10.3201/eid1305.061057|
|AMA||Wallace-Gadsden F, Johnson JR, Wain J, et al. Enteroaggregative Escherichia coli Related to Uropathogenic Clonal Group A. Emerging Infectious Diseases. 2007;13(5):757. doi:10.3201/eid1305.061057.|
|APA||Wallace-Gadsden, F., Johnson, J. R., Wain, J., & Okeke, I. N. (2007). Enteroaggregative Escherichia coli Related to Uropathogenic Clonal Group A. Emerging Infectious Diseases, 13(5), 757. https://dx.doi.org/10.3201/eid1305.061057.|
Enteroaggregative Escherichia coli (EAEC) are heterogeneous, diarrheagenic E. coli. Of EAEC strains from Nigeria, 10 independent antimicrobial-resistant isolates belonged to the multilocus sequence type 69 clonal complex, to which uropathogenic E. coli clonal group A belongs. This finding suggests a recent common ancestor for these distinct groups of pathogenic E. coli.
Enteroaggregative Escherichia coli (EAEC) is an emerging category of diarrheagenic E. coli. EAEC are heterogeneous, and the distribution of known virulence genes rarely correlates with phylogeny based on housekeeping loci (1). We recently identified 2 loci, involved in iron acquisition, that are distributed among EAEC in a manner that correlates with multilocus enzyme electrophoresis typing based on 20 housekeeping enzymes (2). This finding supports the possibility that EAEC clonal groups with increased pathogenic potential exist.
To identify overrepresented subgroups of potential clonal origin, we examined 131 EAEC strains isolated from children in Nigeria (3), 73 from 187 children with diarrhea and 58 from 144 healthy control participants. All 131 strains had previously been categorized as EAEC by the standard HEp-2 cell adherence assay (3,4). To determine flagellin types, we used an RsaI-based PCR–restriction fragment length polymorphism (RFLP) protocol. Using primers F-FLIC1 (5′-ATGGCACAAGTCATTAATACCCAAC-3′) and R-FLIC2 (5′-CTAACCCTGCAGCAGAGACA-3′), we obtained an internal fliC amplicon from 105 (80.1%) of the 131 isolates. RFLP analysis delineated ≥31 flagellin genotypes among these amplicons (Appendix Table). Using 16 control strains, which represented 12 antigenically distinct H-types verified at reference centers, we could associate a specific H antigen with 10 of these RFLP patterns. The most common pattern, which corresponded with the H18 antigen, accounted for 18 (17%) of the genotyped isolates (or 14% of all isolates). Two H7 control strains had different genotypes, which indicates that the products of 2 different alleles are recognized by anti-H7 antiserum. Both genotypes were detected among the test EAEC strains (Appendix Table) and together accounted for 10 (7.6%) of the isolates. Other predominant fliC variants were H2 (3%), H11 (3.8%), H21 (7.6%), and H45 (4.9%). Although some fliC variants were somewhat more common among strains from children with diarrhea than from control participants (Appendix Table), differences were not statistically significant (p>0.05, Fisher exact test).
Antimicrobial susceptibility profiles were determined by disk diffusion as specified by the Clinical and Laboratory Standards Institute (5). Disks containing ampicillin (10 µg), tetracycline (30 µg), trimethoprim (5 µg), nalidixic acid (30 µg), chloramphenicol (30 µg), sulfonamide (300 µg), streptomycin (10 µg), and ciprofloxacin (5 µg) were used for testing on Mueller-Hinton agar (Oxoid, Lenexa, Kansas, USA). Of the 18 Nigerian H18 strains, 13 had the same resistance pattern: ampicillin, chloramphenicol, streptomycin, sulfonamide, tetracycline, trimethoprim (Table 1). PCR identified 3 EAEC-specific and 2 other virulence genes (2,6). Markers of well-characterized aggregative adherence plasmids, present in typical EAEC strains, are aggregative adherence regulator gene aggR, anti-aggregative protein or dispersin gene aap, and empiric plasmid probe (CVD432) that represents part of the aat secretion system operon (6). Of the 131 isolates, <30% harbor these loci (7). However, 17 (89%) of 18 H18-positive EAEC isolates harbored ≥1 of these aggregative adherence plasmid loci, and 15 (83%) of 17 harbored all 3 loci (Table 1). Moreover, 15 (83%) of the 18 isolates contained iucA (aerobactin synthesis), and 17 (94%) contained chuA (heme transport outer-membrane receptor), significantly more than the other 113 EAEC isolates (and 39.8% and 24.8% for iucA and chuA, respectively; p<0.001 for each).
Multidrug-resistant, chuA-positive E. coli H18 strains are also frequently recovered from patients with urinary tract infection. Some of these strains derive from the successful and globally disseminated multidrug-resistant clonal group A (CGA) (8). Uropathogenic E. coli (UPEC) clonal group A strains occur in the United States and Europe; typically exhibit serotypes O11:H18, O17:H18, O73:H18, or O77:H18; and share a common resistance and repetitive element. PCR profile (8). Recently, at certain US centers, ≥33% of trimethoprim-resistant E. coli isolates from uncomplicated cases of pyelonephritis and cystitis have represented CGA (9). CGA strains also can infect nonurinary, extraintestinal sites (10). Furthermore, CGA-like strains have been recovered from human and animal feces, which implies a commensal reservoir (11,12). Accordingly, we assessed our H18 EAEC isolates for membership in CGA.
A CGA-specific PCR protocol, which yields a 175-bp PCR product in strains that have 3 single-nucleotide polymorphisms within fumC (13), was applied to the Nigerian EAEC H18 isolates. Positive controls were 2 reference CGA cystitis isolates with UMN026 and SEQ102 (ATCC BAA-457) (13); negative controls were non-CGA cystitis isolate 2P9 (O15:K52:H1), UPEC isolates CFT073 (O6:K2:H1) and 536 (O6:K15:H31), and an H18 enterotoxigenic E. coli (ETEC) isolate from the Nigeria study (14). Of the 18 EAEC H18 isolates, 10 (including 8 from children with diarrhea) were positive, whereas 8 (and the H18 ETEC isolate) were negative. Lack of obvious familial or temporal clustering of patients from whom these strains were isolated suggests that the isolates are not likely to be directly linked through a single point source. Of 21 other EAEC strains from diverse non-African locales that were similarly screened, including 3 isolates bearing the H18 fliC allele (1), only Thai isolate 144-1 (H18-positive) (1) exhibited the CGA-specific fumC single-nucleotide polymorphisms. The 2 other non-Nigerian H18 EAEC (Peruvian O44:H18 isolate 042 and Thai O36:H18 isolate 44-1) (1) were negative.
To unequivocally assess clonal relationships, we subjected all H18 Nigerian EAEC isolates and the Thai isolate 144-1 to multilocus sequence typing (MLST) (15). Briefly, we sequenced designated internal regions of the adk, fumC, gyrB, icd, mdh, purA, and recA genes. Allele comparisons and sequence type (ST) assignments were done by using the open-source E. coli MLST database (http://web.mpiib-berlin.mpg.de/mlst/dbs/Ecoli). All 11 putative EAEC CGA isolates carried fumC allele 35, which has all 3 targets of the CGA single-nucleotide polymorphism screen (G270A, C271T, and C288T) (13). Of these isolates, 10 (9 Nigerian, 1 Thai) belonged to ST394, which shares 5 of 7 alleles with ST69 (the predominant ST of UPEC CGA; ) and, according to the e-BURST algorithm, is placed with ST69 in the same larger ST69 complex, indicative of a recent common ancestor (15). One Nigerian H18 EAEC isolate, strain E23, was assigned a new ST, ST432, because of its novel purA allele; however, ST432 shares alleles with ST394 at all 6 other loci and so also belongs with the ST69 complex. Of the 8 H18 isolates that were negative in the fumC35 single-nucleotide polymorphism assay, 7 belonged to STs not previously described. Only 1 of these, strain E62 (ST471), shared 6 alleles with ST394 and 4 with ST69. Another strain, C16 (ST512), shared 5 alleles with ST69 and only 4 with ST394. Of the 8 fumC35-negative H18 isolates, 6 did not share 5 alleles with ST69 or ST394 and are therefore considered to be of a different clonal complex. Six fumC35-negative H18 isolates had 6 alleles in common and belonged to 1 of 3 STs: 31, 449, or 474. ST31 includes other EAEC in the MLST database (www.mlst.net). One EAEC H18 isolate shared no allele with any other EAEC isolate from this study (Table 2).
Although iron-utilization genes chuA and iucA are present in all EAEC and UPEC ST69 complex strains, the EAEC virulence plasmid markers aggR, aap, and CVD432 (aat) were found in all 11 EAEC ST394/432 isolates but not in reference UPEC CGA (ST69) isolates (Table 1). EAEC ST394/432 strains and UPEC ST69 (CGA) strains appear to represent diverging lineages of common ancestry, which are adapting to separate niches. Escobar-Paramo (14) proposed that certain E. coli backgrounds appear to be more likely to acquire virulence genes. Our findings suggest that the ST69 complex progenitor, from which CGA UPEC and ST394 EAEC are derived, may have had a propensity to acquire virulence genes as well as antimicrobial resistance elements, thereby generating at least 2 clonal groups pathogenic for humans, with several nonoverlapping, horizontally acquired virulence factors.
CGA-like strains recently isolated from animal feces and food samples have been proposed by Ramchandani et al. (11) as possible reservoirs for UPEC CGA strains. However, although they found similar resistance patterns and serotypes among animal CGA isolates as among humans, they did not find typical UPEC-associated virulence gene profiles (11). Tartof et al. (12) have subsequently shown that CGA-like strains from animal or environmental sources do not belong to ST69 (as do most human UPEC CGA isolates) but that they are part of the ST69 complex, particularly the ST394 type, which corresponds to the EAEC H18 clonal group we describe. Nonhuman ST394 isolates could possibly represent CGA-like EAEC and point to potential nonhuman reservoirs of EAEC, which remain to be identified.
ST69 and ST394 appear to represent successful, genetically related lineages; isolates belonging to both are commonly resistant to ampicillin, chloramphenicol, streptomycin, sulfonamides, tetracycline, and trimethoprim. Widespread use of trimethoprim-sulfamethoxazole has been proposed as a reason for the emergence and spread of UPEC CGA (8). This combination, as well as other drugs to which ST394 strains are typically resistant, is commonly used (and misused) in Nigeria and other developing countries and could provide selective pressure for EAEC ST394/432. Although our numbers were too small to significantly associate ST394/432 strains with disease, 8 of 10 of these isolates were from children with diarrhea. Our study has unveiled what we believe to be a previously unrecognized EAEC clonal group. The fumC single-nucleotide polymorphism method, proposed for identifying UPEC CGA, could be useful for assessing its distribution.
Ms Wallace-Gadsden is a graduate student in the department of microbiology and molecular biology at Tufts University. Her main interests are bacterial colonization and pathogenesis.
We thank Team 56 at the Wellcome Trust Sanger Institute, particularly Nick Matthews, for sequencing. Claire-Louise Crichton, Sheraz Said, and Amanda Muir provided other technical assistance.
This work was funded by a Branco Weiss Fellowship from the Society in Science, Zurich, to I.N.O. F.W.-G. was supported by a Bryn Mawr College Mellon Mays Undergraduate fellowship and a Haverford College Undergraduate Howard Hughes Medical Institute Multicultural scholarship. J.W. was funded by the Wellcome Trust of Great Britain and J.R.J. by the Office of Research and Development, Medical Research Service, Department of Veteran Affairs. J.R.J. has received research grants and consultancies from Ortho-McNeil, Bayer, Wyeth-Ayerst, Merck, Procter & Gamble, and Rochester Medical.
- Czeczulin JR, Whittam TS, Henderson IR, Navarro-Garcia F, Nataro JP. Phylogenetic analysis of virulence genes in enteroaggregative and diffusely adherent Escherichia coli. Infect Immun. 1999;67:2692–9.
- Okeke IN, Scaletsky IC, Soars EH, Macfarlane LR, Torres AG. Molecular epidemiology of the iron utilization genes of enteroaggregative Escherichia coli. J Clin Microbiol. 2004;42:36–44.
- Okeke IN, Lamikanra A, Czeczulin J, Dubovsky F, Kaper JB, Nataro JP. Heterogeneous virulence of enteroaggregative Escherchia coli strains isolated from children in Southwest Nigeria. J Infect Dis. 2000;181:252–60.
- Fields PI, Blom K, Hughes HJ, Helsel LO, Feng P, Swaminathan B. Molecular characterization of the gene encoding H antigen in Escherichia coli and development of a PCR-restriction fragment length polymorphism test for identification of E. coli O157:H7 and O157:NM. J Clin Microbiol. 1997;35:1066–70.
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, 8th Edition; Approved standard. Villanova (PA): The Committee; 2003. p. 130.
- Cerna JF, Nataro JP, Estrada-Garcia T. Multiplex PCR for detection of three plasmid-borne genes of enteroaggregative Escherichia coli strains. J Clin Microbiol. 2003;41:2138–40.
- Okeke IN, Lamikanra A, Steinruck H, Kaper JB. Characterization of Escherichia coli strains from cases of childhood diarrhea in provincial southwestern Nigeria. J Clin Microbiol. 2000;38:7–12.
- Johnson JR, Manges AR, O'Bryan TT, Riley LW. A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet. 2002;359:2249–51.
- Manges AR, Johnson JR, Foxman B, O’Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med. 2001;345:1007–13.
- Manges AR, Perdreau-Remington F, Solberg O, Riley LW. Multidrug-resistant Escherichia coli clonal groups causing community-acquired bloodstream infections. J Infect. 2005;53:25–9.
- Ramchandani M, Manges AR. DebRoy C, Smith SP, Johnson JR, Riley LW. Possible animal origin of human-associated, multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis. 2005;40:251–7.
- Tartof SY, Solberg OD, Manges AR, Riley LW. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol. 2005;43:5860–4.
- Johnson JR, Owens K, Manges AR, Riley LW. Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR. J Clin Microbiol. 2004;42:2618–22.
- Escobar-Paramo P, Clermont O, Blanc-Potard AB, Bui H, Le Bouguenec C, Denamur E. A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. Mol Biol Evol. 2004;21:1085–94.
- Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol. 2006;60:1136–51.
- Table 1. Properties of H18 EAEC isolates and selected reference strains
- Table 2. Multilocus sequence types of CGA-associated fumC single-nucleotide polymorphism–positive strains
- Flagellin types of EAEC strains isolated from Nigerian children identified by PCR-RFLP* 15 KB
Please use the form below to submit correspondence to the authors or contact them at the following address:
Iruka N. Okeke, Department of Biology, Haverford College, 370 Lancaster Ave, Haverford, PA 19041, USA;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: June 23, 2010
- Page last updated: June 23, 2010
- Page last reviewed: June 23, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)